TERF2IP and central nervous system cancer: EV-miR-1246 from hypoxic glioma cells reprograms macrophages into M2 phenotype by targeting TERF2IP, which further enhances the proliferation, migration and invasion of glioma cells in vitro and in vivo probably by secreting IL10, TGF-β [231].